The company agreed to sell 4 series of Notes: 4.400% notes due June 15, 2028, 4.650% notes due January 15, 2031, 5.300% notes due June 15, 2035 and 5.950% notes due June 15, 2055, issued on June 17, 2025.

1. 01

   The company agreed to sell 4 series of Notes: 4.400% notes due June 15, 2028, 4.650% notes due January 15, 2031, 5.300% notes due June 15, 2035 and 5.950% notes due June 15, 2055, issued on June 17, 2025.

2. 02

   The company said the aggregate principal amount for each series was 4.400% Notes at $500,000,000, 4.650% Notes at $750,000,000, 5.300% Notes at $1,000,000,000 and 5.950% Notes at $750,000,000.

3. 03

   UnitedHealth said it entered into the Underwriting Agreement and Pricing Agreement with BofA Securities, Barclays, Citigroup Global Markets and J.P. Morgan Securities on June 17, 2025, and that the Notes were issued on June 20, 2025.

4. 04

   The company said the Notes were issued on February 4, 2008 under the Indenture, with U.S. Bank Trust Company, National Association as trustee, and were registered on Form S-3 automatic shelf registration statement (File No. 333-270279).

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.